Cardiovascular Disease

National Geographic: ‘Super antigens’ tied to mysterious COVID-19 syndrome in children

October 22, 2020
 

Dr. Alvaro Moreira, Neonatology, is quoted in this National Geographic story regarding a study by his team on “super antigens” that are tied to a mysterious COVID-19 syndrome in children, following the coronavirus inhabiting the gut; see link at “early signs” in the third paragraph. Read the story.


Magnesium energetics

Researchers solve 100-year-old mystery of what activates magnesium ions in the cell

October 15, 2020
 

The discovery is expected to be a springboard for future development of novel drugs to treat cardiovascular disease, metabolic disorders such as diabetes and other diseases.



Magnesium energetics

Groundbreaking study finds activator of magnesium dynamics in the body

October 8, 2020
 

Discovery seen as avenue to develop novel therapies for many conditions. Researchers from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) have solved the 100-year-old mystery of what activates magnesium ions in the cell. The discovery is expected to be a springboard for future development of novel drugs to […]



Cardiovascular Business: Chemotherapy could be damaging children’s heart cells, leading to problems later in life

October 1, 2020
 

Results published in the journal PLOS ONE show that 20% of children treated with drugs called anthracyclines go on to suffer heart failure later in life. The research is conducted in the laboratory of Gregory Aune, MD, PhD, of the Department of Pediatrics and the Greehey Children’s Cancer Research Institute at UT Health San Antonio. Read […]



Clues sought for why pediatric cancer survivors develop heart failure

September 25, 2020
 

Cancer chemotherapy changes the function of cells that repair heart injury, researchers at UT Health San Antonio discovered. Twenty percent of children treated with drugs called anthracyclines go on to suffer heart failure later in life.



Heart

Study: Childhood chemo alters heart’s caretaker cells

September 25, 2020
 

Clues sought for why 1 in 5 pediatric cancer survivors develop heart failure. Cancer chemotherapy changes the function of cells that repair heart injury, researchers at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) discovered. Twenty percent of children treated with drugs called anthracyclines go on to suffer heart […]